Key facts for DRG 823
- FY2027 relative weight
- 4.6059
- Higher than 89% of all MS-DRGs
- Change vs FY2026
- +0.5%
- FY2026 weight 4.5848
- Geometric mean LOS
- 9.9 days
- Arithmetic mean 13.2 days
- MDC
- 17
- Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms
- Severity level
- with MCC (major complication or comorbidity)
- National unadjusted operating payment
- $31,541.20
- Weight × $6,848.00 FY2027 standardized amount; capital adds $2,486.96
- Transfer policy
- Not a transfer DRG
TL;DR
MS-DRG 823 is a surgical group in MDC 17 (Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms), at the highest of three severity levels in its CC/MCC family. CMS assigns it a FY2027 relative weight of 4.6059 with a geometric mean length of stay of 9.9 days and an arithmetic mean of 13.2. Its weight moved up 0.5% from FY2026 (4.5848). That weight is higher than 89% of all MS-DRGs. Its weight sits 104.6% above DRG 824 (with CC, 2.2515) and 254.4% above DRG 825 (without CC/MCC, 1.2995). The v44 Definitions Manual assigns it through 519 principal diagnosis codes and 189 non-operating room procedures codes.
What changed from FY2026 to FY2027
CMS recalibrates every MS-DRG weight annually from the prior year's MedPAR claims. For DRG 823 the FY2027 relative weight is 4.6059 against 4.5848 in FY2026, a rise of 0.46%.
| Metric | FY2026 | FY2027 | Change |
|---|---|---|---|
| Relative weight | 4.5848 | 4.6059 | +0.0211 |
| Geometric mean LOS (days) | 10.1 | 9.9 | -0.2 |
| Arithmetic mean LOS (days) | 13.6 | 13.2 | -0.4 |
CC and MCC family
DRG 823 shares its base definition with 2 other MS-DRGs split by severity. The family's weights span 1.2995 to 4.6059, a 3.54× spread, which is the payment effect of documenting qualifying complications and comorbidities.
| DRG | Title | FY2027 weight | GMLOS | National operating payment |
|---|---|---|---|---|
| 823 | Lymphoma and Non-Acute Leukemia with Other Procedures with MCC | 4.6059 | 9.9 | $31,541.20 |
| 824 | Lymphoma and Non-Acute Leukemia with Other Procedures with CC | 2.2515 | 4.9 | $15,418.27 |
| 825 | Lymphoma and Non-Acute Leukemia with Other Procedures without CC/MCC | 1.2995 | 2.2 | $8,898.98 |
At the national rate, documenting the family's top severity level (DRG 823, $31,541.20) instead of its base level (DRG 825, $8,898.98) changes the operating payment by $22,642.23, the amount at stake when a reviewer removes the MCC or CC that put the stay here. The figures are national operating amounts before the hospital-specific adjustments described below.
National unadjusted payment for DRG 823
Multiplying the FY2027 relative weight (4.6059) by the national rates in IPPS Tables 1A and 1D, as corrected by notice CMS-1849-CN3, gives the base amounts below. Across the CC/MCC family the operating amount spans $22,642.23.
| Component | National rate | DRG 823 |
|---|---|---|
| Operating (labor and nonlabor share) | $4,519.68 + $2,328.32 = $6,848.00 | $31,541.20 |
| Capital (federal rate) | $539.95 | $2,486.96 |
| Operating plus capital | $34,028.16 |
These are national, unadjusted figures, not what a given hospital is paid. The labor share is multiplied by the hospital's wage index (Table 1A applies when the wage index is above 1.0 and Table 1B otherwise), and teaching (IME), disproportionate share (DSH), outlier, transfer and new-technology add-on rules then change the amount for each stay. Use the figures to compare groups and to size a documentation finding, not to forecast a remittance; the DRG payment calculator applies a hospital's own wage index and teaching and DSH factors to DRG 823.
Risk-adjusting diagnoses in this DRG
Appendix B of the v44 Definitions Manual lists 519 ICD-10-CM codes in the logic for DRG 823; 515 of them also map to a CMS-HCC V28 payment category, across 8 categories. The same documentation that supports the inpatient group feeds Medicare Advantage risk adjustment when the patient is an MA enrollee.
| V28 HCC | Category | Shared codes | Examples |
|---|---|---|---|
| HCC 21 | Lymphoma and Other Cancers | 278 | C46.3, C81.00, C81.01 |
| HCC 20 | Lung and Other Severe Cancers | 139 | C77.3, C83.10, C83.11 |
| HCC 19 | Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers | 52 | C84.40, C84.41, C84.42 |
| HCC 22 | Bladder, Colorectal, and Other Cancers | 22 | C26.1, C91.10, C91.11 |
| HCC 17 | Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic | 17 | C77.1, C77.8, C7B.01 |
| HCC 18 | Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid | 5 | C77.0, C77.2, C77.4 |
| HCC 23 | Prostate, Breast, and Other Cancers and Tumors | 1 | D45 |
| HCC 109 | Acquired Hemolytic, Aplastic, and Sideroblastic Anemias | 1 | D61.82 |
Grouper logic (v44 Definitions Manual)
The manual's split table for Lymphoma and Non-Acute Leukemia with Other Procedures gives one row per combination of criteria and the MS-DRG it assigns. DRG 823 is the row where MCC is Yes.
Criteria stated in the manual
- Any other operating room procedure not listed in DRGs 820-822
- Any of the following non-operating room procedures
Principal Diagnosis: 519 ICD-10-CM codes in this DRG's assignment logic; the first 12 are shown.
| ICD-10-CM code | Description |
|---|---|
| C26.1 | Malignant neoplasm of spleen |
| C46.3 | Kaposi's sarcoma of lymph nodes |
| C77.0 | Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck |
| C77.1 | Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes |
| C77.2 | Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes |
| C77.3 | Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes |
| C77.4 | Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes |
| C77.5 | Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes |
| C77.8 | Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions |
| C77.9 | Secondary and unspecified malignant neoplasm of lymph node, unspecified |
| C7B.01 | Secondary carcinoid tumors of distant lymph nodes |
| C81.00 | Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site |
Non-Operating Room Procedures: 189 ICD-10-PCS codes in this DRG's assignment logic; the first 12 are shown. The manual joins this list to the one before it with "or".
| ICD-10-PCS code | Description |
|---|---|
| D020DZZ | Stereotactic Other Photon Radiosurgery of Brain |
| D020HZZ | Stereotactic Particulate Radiosurgery of Brain |
| D020JZZ | Stereotactic Gamma Beam Radiosurgery of Brain |
| D021DZZ | Stereotactic Other Photon Radiosurgery of Brain Stem |
| D021HZZ | Stereotactic Particulate Radiosurgery of Brain Stem |
| D021JZZ | Stereotactic Gamma Beam Radiosurgery of Brain Stem |
| D026DZZ | Stereotactic Other Photon Radiosurgery of Spinal Cord |
| D026HZZ | Stereotactic Particulate Radiosurgery of Spinal Cord |
| D026JZZ | Stereotactic Gamma Beam Radiosurgery of Spinal Cord |
| D027DZZ | Stereotactic Other Photon Radiosurgery of Peripheral Nerve |
| D027HZZ | Stereotactic Particulate Radiosurgery of Peripheral Nerve |
| D027JZZ | Stereotactic Gamma Beam Radiosurgery of Peripheral Nerve |
Code editor, HAC and CC/MCC exclusion notes for DRG 823
Because this family splits by CC and MCC, a secondary diagnosis on the hospital-acquired condition list that is reported with a present-on-admission indicator of N or U does not count toward the severity level, and a CC or MCC excluded by the principal diagnosis does not count either. Check a secondary diagnosis and its CC exclusion before relying on it for the higher member.
The Definitions Manual lists the diagnosis and procedure codes that lead to DRG 823; these are the ones that are also on a Medicare Code Editor list and can draw that edit.
| MCE edit | List | Codes | Examples |
|---|---|---|---|
| Edit 4 | age conflict: pediatric diagnosis (age 0 to 17) | 3 | C93.30, C93.31, C93.32 |
| Edit 4 | age conflict: adult diagnosis (age 15 to 124) | 3 | C91.50, C91.51, C91.52 |
| Edit 6 | manifestation code, not allowed as principal diagnosis | 1 | D75.81 |
| Edit 11 | leukemia that makes autologous marrow or stem cell transfusion non-covered | 2 | C92.10, C92.11 |
Documentation and denial exposure
As a surgical DRG, assignment depends on a qualifying operating-room procedure being coded from the operative report; a missing or non-OR procedure code drops the stay into a medical DRG in MDC 17 with a lower weight. The inpatient claim reports that procedure in ICD-10-PCS, which NCCI does not edit; the surgeon's professional claim for the same operation carries CPT and HCPCS codes, and the NCCI pair checker for those professional codes shows whether two of them bundle. Because this family splits by severity, auditors target CC and MCC capture: each secondary diagnosis must be documented as present, monitored, evaluated or treated during the stay to survive a DRG-validation review. Typical inpatient denial codes for this group: CARC 16 (claim lacks information needed to group the stay), CARC 50 (the admission or procedure is judged not medically necessary), CARC 97 (a service is bundled into the DRG payment).
For teams evaluating QuickIntell software
Evaluate a documentation and coding workflow for DRG 823
Explore QuickCode for qualified coder review and documentation clarification, or QuickScribe for clinician-reviewed visit documentation. Confirm inpatient scope, the supported grouper version and reviewer responsibilities during evaluation. This public reference is not a production grouper and does not determine a claim's reimbursement.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions — DRG 823
What is MS-DRG 823?
MS-DRG 823 is "Lymphoma and Non-Acute Leukemia with Other Procedures with MCC", a surgical Medicare Severity Diagnosis-Related Group in MDC 17 (Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms). Medicare pays inpatient stays grouped here at the hospital's base rate multiplied by the DRG relative weight.
What is the FY2027 relative weight for DRG 823?
The FY2027 relative weight is 4.6059 (IPPS final rule Table 5, effective October 1, 2026). In FY2026 it was 4.5848, a change of +0.5%.
What is the Medicare base payment for MS-DRG 823?
$31,541.20 for operating costs plus $2,486.96 for capital, $34,028.16 together, at the FY2027 national rates: weight 4.6059 times the $6,848.00 operating standardized amount and the $539.95 capital rate (IPPS Tables 1A and 1D as corrected by CMS-1849-CN3). DRG 824 (with CC) comes to $15,418.27 operating on the same basis. DRG 825 (without CC/MCC) comes to $8,898.98 operating on the same basis. The hospital's wage index, IME, DSH, outlier and transfer adjustments change what a given stay is paid.
What is the average length of stay for DRG 823?
CMS reports a geometric mean length of stay of 9.9 days and an arithmetic mean of 13.2 days for FY2027. The geometric mean is used for transfer-payment calculations.
Which DRGs are in the same CC/MCC family as 823?
DRG 824 (with CC, weight 2.2515, GMLOS 4.9 days); DRG 825 (without CC/MCC, weight 1.2995, GMLOS 2.2 days). Together with DRG 823 the family spans 1.2995 to 4.6059, a 3.54x spread, so documented complications and comorbidities change payment materially.
What documentation supports the severity level of DRG 823?
DRG 823 requires at least one secondary diagnosis on the CMS Major Complication or Comorbidity list, documented as present and clinically addressed during the stay (monitored, evaluated, treated or extending the stay). Conditions such as acute respiratory failure, severe sepsis or acute kidney injury with specified cause qualify only when the attending's note states the diagnosis itself, not just the lab values. Recovery auditors downgrade this group to the CC or base level when the MCC rests on an unconfirmed query or a resolved historical condition, so the query response and the discharge summary must agree.
Which codes group to DRG 823?
The v44 Definitions Manual lists 519 principal diagnosis codes and 189 non-operating room procedures codes for this group. Examples from the principal diagnosis list, C26.1 (Malignant neoplasm of spleen); C46.3 (Kaposi's sarcoma of lymph nodes); and from the non-operating room procedures list, D020DZZ (Stereotactic Other Photon Radiosurgery of Brain); D020HZZ (Stereotactic Particulate Radiosurgery of Brain).
Is DRG 823 a post-acute transfer DRG?
No. DRG 823 is not on the FY2027 post-acute care transfer list, so the transfer per-diem policy does not apply to it.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- IPPS FY2027 Table 5 as corrected by correction notice CMS-1849-CN3Version v44 FY2027 (final rule + CN3) · effective 2026-10-01 · file CMS-1849-CN Table 5.txtSHA-256 2cc4e0b083e62e40…
- IPPS FY2026 Final Rule Table 5 (CMS-1833-F)Version v43 FY2026 · effective 2025-10-01 · file CMS-1833-F Table 5.txtSHA-256 bf8c390d14b3cd3e…
- ICD-10 MS-DRG Definitions Manual v44 (text)Version v44 · effective 2026-10-01 · file fy2027-fr-icd10-ms-drg-definitions-manual-files-v44.zipSHA-256 ae4f6c11727fe91f…
Disclaimer
This page is an operational reference compiled from the CMS IPPS FY2027 final rule (Table 5) and the v44 ICD-10 MS-DRG Definitions Manual. Relative weights are national factors; actual payment depends on each hospital's wage-adjusted base rate, add-ons, outliers and transfer adjustments. Nothing here is legal, clinical or billing advice; verify grouping against your encoder and the published CMS files.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.